A Combination of Rituximab and CC-99282 As Front-line Therapy for Older Frail Patients with Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated with a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)
- Conditions
- Diffuse Large B Cell Non-Hodgkin Lymphoma
- Interventions
- Drug: Rituximab + Golcadomide (CC-99282)
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 47
- Registration Number
- NCT06835530
- Locations
- 🇮🇹
AOU SS. Antonio e Biagio e Cesare Arrigo di Alessandria - SCDU Ematologia, Alessandria, Italy
🇮🇹AOU Ospedali Riuniti - Clinica di Ematologia, Ancona, Italy
🇮🇹Azienda Ospedaliera S. Giuseppe Moscati - S.C. Ematologia e trapianto emopoietico, Avellino, Italy
Study on Plasmablastic Lymphoma Patients
- Conditions
- Plasmablastic Lymphoma
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 200
- Registration Number
- NCT06781359
- Locations
- 🇮🇹
IRCCS Centro di Riferimento Oncologico di Aviano, Divisione di Oncologia e dei Tumori immuno-correlati, Aviano, PN, Italy
🇮🇹Azienda Ospedaliera Universitaria Careggi, Unità funzionale di Ematologia, Firenze, Italy
🇮🇹ASST -Fatebenefratelli - Polo Luigi Sacco Oncologia, Milano, Italy
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
- Conditions
- Cutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 400
- Registration Number
- NCT06588868
- Locations
- 🇮🇹
U.O.C. Clinica Dermatologica - A.O.U. di Padova, Padova, Italy
🇮🇹U.O.C Ematologia 1 - IRCCS Fondazione Policlinico San Matteo, Pavia, Italy
🇮🇹AOU Ospedali Riuniti delle Marche - Clinica di Ematologia, Ancona, Italy
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
- Conditions
- Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 200
- Registration Number
- NCT06588205
- Locations
- 🇮🇹
U.O.C. Ematologia - A.O.U. Senese, Siena, Italy
🇮🇹A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia, Alessandria, Italy
🇮🇹A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia, Ancona, Italy
Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients
- Conditions
- Follicular Lymphoma
- Interventions
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 56
- Registration Number
- NCT06492837
- Locations
- 🇮🇹
ASST Grande Ospedale Metropolitano Niguarda, SC Ematologia, Milano, Italy
🇮🇹IRCCS Istituto Tumori Giovanni Paolo II, U.O.C Ematologia, Bari, Italy
🇮🇹A.O.U. Città della Salute e della Scienza di Torino, S.C.Ematologia, Torino, Italy
Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 125
- Registration Number
- NCT06441214
- Locations
- 🇮🇹
Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia, Firenze, Italy
🇮🇹A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia, Alessandria, Italy
🇮🇹A.O.U. Ospedali Riuniti - Clinica di Ematologia, Ancona, Italy
PTLD: Multicentric Retrospective Study
- Conditions
- PTLD
- First Posted Date
- 2024-05-21
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 200
- Registration Number
- NCT06422715
- Locations
- 🇮🇹
Centro Di Riferimento Oncologico Di Aviano, S.O.C. Oncologia Medica e dei Tumori Immunocorrelati, Aviano, Italy
🇮🇹A.O. Spedali Civili di Brescia - Ematologia, Brescia, Italy
🇮🇹Istituto Scientifico San Raffaele - Unitа Linfomi - Dipartimento Oncoematologia, Milano, Italy
SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project
- Conditions
- Non-hodgkin Lymphoma,B Cell
- Interventions
- Other: Chimeric Antigen Receptor T-cells (CAR-T) therapy
- First Posted Date
- 2023-12-05
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 130
- Registration Number
- NCT06156774
- Locations
- 🇮🇹
A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia, Alessandria, Italy
🇮🇹AOU Ospedali Riuniti - Clinica di Ematologia, Ancona, Italy
🇮🇹Azienda Ospedaliera S .Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico, Avellino, Italy
Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
- Conditions
- Cutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Sezary Syndrome
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 150
- Registration Number
- NCT06113081
- Locations
- 🇮🇹
U.O.C. di Ematologia - A.O.U. Policlinico S. Marco, Catania, Italy
🇮🇹Clinica di Ematologia - AOU Ospedali Riuniti delle Marche, Ancona, Italy
🇮🇹S.C. Ematologia e Trapianto emopoietico - A.O. S.Giuseppe Moscati, Avellino, Italy
Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
- Conditions
- Follicular Lymphoma
- Interventions
- Diagnostic Test: Cellular immunity vs SARS-CoV-2Diagnostic Test: Humoral immunity vs SARS-CoV-2Diagnostic Test: Cellular immunity vs Varicella Zoster VirusDiagnostic Test: Humoral immunity vs Varicella Zoster VirusDiagnostic Test: Diphtheria toxin-binding IgGDiagnostic Test: Tetanus toxoid-binding IgGDiagnostic Test: T-cell populations and markers characterization
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Fondazione Italiana Linfomi - ETS
- Target Recruit Count
- 56
- Registration Number
- NCT06070961
- Locations
- 🇮🇹
A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia, Alessandria, IT, Italy
🇮🇹Nuovo Ospedale degli Infermi, SSD Ematologia, Biella, IT, Italy
🇮🇹ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia, Milano, IT, Italy